We are currently enrolling patients for ANX-514 (docetaxel emulsion): "A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients with Advanced Cancer." Please click
here
for more information regarding this study.
COMPANY
|
PRODUCTS
| CLINICAL TRIALS |
PARTNERS
|
INVESTORS
|
RESOURCES
|
CONTACT
HOME
|
CAREERS
|
SEARCH
|
SITE MAP
|
HELP
|
LEGAL
© Copyright 2008 ADVENTRX Pharmaceuticals
